Aurobindo Pharma Ltd. | AUROPHARMA | NSE - Pharmaceuticals


Performance Valuation Growth Insiders Summary Balance Sheet Income Statement Cash Flow Quarterly
INR in Million. Fiscal year ends in March. Figures are consolidated and restated..

Upgrade Membership to see 10 year accurate financial statements.
 Chart
2017
2018
2019
2020
2021
Revenue
Revenue
150,899164,998195,636230,985247,746
Cost of revenue
Cost of revenue
-64,343-67,527-87,126-97,352-99,025
Gross Profit
Gross Profit
86,556
97,471
108,509
133,633
148,722
Sales, general & ad...
Sales, general and administrative
-52,213-59,753-68,990-84,990-95,387
Depreciation
Depreciation and amortization
-4,276-5,580-6,680-9,667-10,554
Provision
Provision
00000
Other op inc/exp...
Other operating income/expenses
00000
Operating income
Operating income EBIT
30,067
32,138
32,840
38,976
42,780
 
      
Profit before tax
Profit before tax
30,55832,38030,88737,58273,990
Net Income
Net income
23,017
24,229
23,645
28,310
53,328
 
 
 
 
 
 
 
EPS Basic
EPS Basic in Rupees
39.33
41.35
40.36
48.32
91.01